{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T22:24:53Z","timestamp":1788042293533,"version":"build-2784847793"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-03992-y","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:03:04Z","timestamp":1759273384000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Safety and pathological impact of resection after high-dose PBT for locally advanced pancreatic cancer"],"prefix":"10.1186","volume":"23","author":[{"given":"Osamu","family":"Shimomura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruko","family":"Numajiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manami","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Nakahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Hiroshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Niisato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan J.","family":"Mathis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiichiro","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"issue":"10242","key":"3992_CR1","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/s0140-6736(20)30974-0","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. Lancet. 2020;395(10242):2008\u201320. https:\/\/doi.org\/10.1016\/s0140-6736(20)30974-0.","journal-title":"Lancet"},{"issue":"5","key":"3992_CR2","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41571-023-00746-1","volume":"20","author":"C Springfeld","year":"2023","unstructured":"Springfeld C, Ferrone CR, Katz MHG, Philip PA, Hong TS, Hackert T, et al. Neoadjuvant therapy for pancreatic cancer. Nat Rev Clin Oncol. 2023;20(5):318\u201337. https:\/\/doi.org\/10.1038\/s41571-023-00746-1.","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"3992_CR3","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/s1470-2045(16)00172-8","volume":"17","author":"M Suker","year":"2016","unstructured":"Suker M, Beumer BR, Sadot E, Marthey L, Faris JE, Mellon EA, et al. FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis. Lancet Oncol. 2016;17(6):801\u201310. https:\/\/doi.org\/10.1016\/s1470-2045(16)00172-8.","journal-title":"Lancet Oncol"},{"issue":"9","key":"3992_CR4","doi-asserted-by":"publisher","first-page":"6180","DOI":"10.1245\/s10434-024-15591-4","volume":"31","author":"RT Theijse","year":"2024","unstructured":"Theijse RT, Stoop TF, Leenart PD, Lutchman KRD,Erdmann JI, Daams F, et al. Surgery for locally advanced pancreatic cancer following induction chemotherapy: A Single-Center experience. Ann Surg Oncol. 2024;31(9):6180\u201392. https:\/\/doi.org\/10.1245\/s10434-024-15591-4.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"3992_CR5","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/jjco\/hyw102","volume":"46","author":"H Sakurai","year":"2016","unstructured":"Sakurai H, Ishikawa H, Okumura T. Proton beam therapy in japan: current and future status. Jpn J Clin Oncol. 2016;46(10):885\u201392. https:\/\/doi.org\/10.1093\/jjco\/hyw102.","journal-title":"Jpn J Clin Oncol"},{"issue":"8","key":"3992_CR6","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1245\/s10434-019-07471-z","volume":"26","author":"T Mizumoto","year":"2019","unstructured":"Mizumoto T, Terashima K, Matsuo Y, Nagano F, Demizu Y, Mima M, et al. Proton radiotherapy for isolated local recurrence of primary resected pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2019;26(8):2587\u201394. https:\/\/doi.org\/10.1245\/s10434-019-07471-z.","journal-title":"Ann Surg Oncol"},{"key":"3992_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.radonc.2019.03.012","volume":"136","author":"Y Hiroshima","year":"2019","unstructured":"Hiroshima Y, Fukumitsu N, Saito T, Numajiri H, Murofushi KN, Ohnishi K, et al. Concurrent chemoradiotherapy using proton beams for unresectable locally advanced pancreatic cancer. Radiother Oncol. 2019;136:37\u201343. https:\/\/doi.org\/10.1016\/j.radonc.2019.03.012.","journal-title":"Radiother Oncol"},{"key":"3992_CR8","doi-asserted-by":"publisher","first-page":"101542","DOI":"10.1016\/j.suronc.2021.101542","volume":"37","author":"O Shimomura","year":"2021","unstructured":"Shimomura O, Oda T, Hashimoto S, Doi M, Hiroshima Y, Numajiri H, et al. Survival impact on triple-modal strategy comprising hyperthermia, external radiation, and chemotherapy for unresectable locally advanced (UR-LA) pancreatic ductal adenocarcinoma. Surg Oncol. 2021;37:101542. https:\/\/doi.org\/10.1016\/j.suronc.2021.101542.","journal-title":"Surg Oncol"},{"issue":"20","key":"3992_CR9","doi-asserted-by":"publisher","first-page":"20450","DOI":"10.1002\/cam4.6611","volume":"12","author":"Y Hiroshima","year":"2023","unstructured":"Hiroshima Y, Kondo M, Sawada T, Hoshi SL, Okubo R, Iizumi T, et al. Analysis of the cost-effectiveness of proton beam therapy for unresectable pancreatic cancer in Japan. Cancer Med. 2023;12(20):20450\u20138. https:\/\/doi.org\/10.1002\/cam4.6611.","journal-title":"Cancer Med"},{"issue":"1","key":"3992_CR10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/s0360-3016(00)00522-8","volume":"48","author":"A Zurlo","year":"2000","unstructured":"Zurlo A, Lomax A, Hoess A, Bortfeld T, Russo M, Goitein G, et al. The role of proton therapy in the treatment of large irradiation volumes: a comparative planning study of pancreatic and biliary tumors. Int J Radiat Oncol Biol Phys. 2000;48(1):277\u201388. https:\/\/doi.org\/10.1016\/s0360-3016(00)00522-8.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"3992_CR11","doi-asserted-by":"publisher","first-page":"166","DOI":"10.21037\/jgo.2019.03.02","volume":"11","author":"MS Rutenberg","year":"2020","unstructured":"Rutenberg MS, Nichols RC. Proton beam radiotherapy for pancreas cancer. J Gastrointest Oncol. 2020;11(1):166\u201375. https:\/\/doi.org\/10.21037\/jgo.2019.03.02.","journal-title":"J Gastrointest Oncol"},{"issue":"19","key":"3992_CR12","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","volume":"364","author":"T Conroy","year":"2011","unstructured":"Conroy T, Desseigne F, Ychou M, Bouche O, Guimbaud R, Becouarn Y, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. New Engl J Med. 2011;364(19):1817\u201325. https:\/\/doi.org\/10.1056\/NEJMoa1011923.","journal-title":"New Engl J Med"},{"issue":"18","key":"3992_CR13","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","volume":"369","author":"DD Von Hoff","year":"2013","unstructured":"Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. New Engl J Med. 2013;369(18):1691\u2013703. https:\/\/doi.org\/10.1056\/NEJMoa1304369.","journal-title":"New Engl J Med"},{"issue":"6","key":"3992_CR14","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1007\/s00534-013-0616-0","volume":"20","author":"S Satoi","year":"2013","unstructured":"Satoi S, Yamaue H, Kato K, Takahashi S, Hirono S, Takeda S, et al. Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long-term favorable response to non-surgical anti-cancer treatments: results of a project study for pancreatic surgery by the Japanese society of Hepato-Biliary-Pancreatic surgery. J Hepatobiliary Pancreat Sci. 2013;20(6):590\u2013600. https:\/\/doi.org\/10.1007\/s00534-013-0616-0.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"3992_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/jhbp.12066","author":"N Okano","year":"2024","unstructured":"Okano N, Kawai M, Ueno M, Yu X, Inoue Y, Takahashi S, et al. Outcomes of patients with initially unresectable pancreatic cancer who underwent conversion surgery after FOLFIRINOX or gemcitabine plus nab-paclitaxel chemotherapy: A multicenter retrospective cohort study (PC-CURE-1). J Hepatobiliary Pancreat Sci. 2024. https:\/\/doi.org\/10.1002\/jhbp.12066.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"11","key":"3992_CR16","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/jhbp.12056","volume":"31","author":"M Ishida","year":"2024","unstructured":"Ishida M, Fujii T, Kishiwada M, Shibuya K, Satoi S, Ueno M, et al. Japanese classification of pancreatic carcinoma by the Japan pancreas society: eighth edition. J Hepatobiliary Pancreat Sci. 2024;31(11):755\u201368. https:\/\/doi.org\/10.1002\/jhbp.12056.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"10041","key":"3992_CR17","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/s0140-6736(16)30583-9","volume":"388","author":"K Uesaka","year":"2016","unstructured":"Uesaka K, Boku N, Fukutomi A, Okamura Y, Konishi M, Matsumoto I, et al. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01). Lancet. 2016;388(10041):248\u201357. https:\/\/doi.org\/10.1016\/s0140-6736(16)30583-9.","journal-title":"Lancet"},{"issue":"11","key":"3992_CR18","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1007\/s00432-015-1974-6","volume":"141","author":"JM Straub","year":"2015","unstructured":"Straub JM, New J, Hamilton CD, Lominska C, Shnayder Y, Thomas SM. Radiation-induced fibrosis: mechanisms and implications for therapy. J Cancer Res Clin Oncol. 2015;141(11):1985\u201394. https:\/\/doi.org\/10.1007\/s00432-015-1974-6.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"16","key":"3992_CR19","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1200\/jco.19.02274","volume":"38","author":"E Versteijne","year":"2020","unstructured":"Versteijne E, Suker M, Groothuis K, Akkermans-Vogelaar JM, Besselink MG, Bonsing BA, et al. Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: results of the Dutch randomized phase III PREOPANC trial. J Clin Oncol. 2020;38(16):1763\u201373. https:\/\/doi.org\/10.1200\/jco.19.02274.","journal-title":"J Clin Oncol"},{"issue":"4","key":"3992_CR20","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1097\/sla.0000000000005507","volume":"277","author":"L Wang","year":"2023","unstructured":"Wang L, Zhang XY, Zhao YM, Li SJ, Li ZW, Sun YS, et al. Intentional watch and wait or organ preservation surgery following neoadjuvant chemoradiotherapy plus consolidation CAPEOX for MRI-defined Low-risk rectal cancer: findings from a prospective phase 2 trial (PKUCH-R01 trial, NCT02860234). Ann Surg. 2023;277(4):647\u201354. https:\/\/doi.org\/10.1097\/sla.0000000000005507.","journal-title":"Ann Surg"},{"issue":"5","key":"3992_CR21","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1245\/s10434-025-16956-z","volume":"32","author":"K Yamane","year":"2025","unstructured":"Yamane K, Anazawa T, Nagai K, Kasai Y, Masui T, Izuwa A, et al. Neoadjuvant chemoradiotherapy using moderately hypofractionated Intensity-Modulated radiotherapy versus upfront surgery for resectable pancreatic cancer: A retrospective cohort study. Ann Surg Oncol. 2025;32(5):3603\u201313. https:\/\/doi.org\/10.1245\/s10434-025-16956-z.","journal-title":"Ann Surg Oncol"},{"key":"3992_CR22","doi-asserted-by":"publisher","first-page":"110347","DOI":"10.1016\/j.radonc.2024.110347","volume":"197","author":"M Weisz Ejlsmark","year":"2024","unstructured":"Weisz Ejlsmark M, Bahij R, Schytte T, R\u00f8nn Hansen C, Bertelsen A, Mahmood F, et al. Adaptive MRI-guided stereotactic body radiation therapy for locally advanced pancreatic cancer - A phase II study. Radiother Oncol. 2024;197:110347. https:\/\/doi.org\/10.1016\/j.radonc.2024.110347.","journal-title":"Radiother Oncol"},{"issue":"1","key":"3992_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s13014-017-0923-8","volume":"12","author":"NR Datta","year":"2017","unstructured":"Datta NR, Pestalozzi B, Clavien PA, Siebenhuner A, Puric E, Khan S, et al. HEATPAC - a phase II randomized study of concurrent thermochemoradiotherapy versus chemoradiotherapy alone in locally advanced pancreatic cancer. Radiat Oncol. 2017;12(1):183. https:\/\/doi.org\/10.1186\/s13014-017-0923-8.","journal-title":"Radiat Oncol"},{"key":"3992_CR24","doi-asserted-by":"publisher","unstructured":"Shimomura O, EndoM, Makishima H, Yamada T, Hashimoto S, Numajiri H., et al. Triple modal treatment comprisingwith proton beam radiation, hyperthermia, and gemcitabine\/nab-paclitaxel for locally advanced pancreatic cancer: a phase I\/II study protocol (TT-LAP trial). BMC Cancer. 2023;23(1):624. https:\/\/doi.org\/10.1186\/s12885-023-11110-y.","DOI":"10.1186\/s12885-023-11110-y"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03992-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-03992-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03992-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:03:04Z","timestamp":1759273384000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-03992-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3992"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-03992-y","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"23 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been done in accordance with the Declaration of Helsinki on research ethics. All patients\u2019 data was collected after approval from the Institutional Review Board (Ethical committee, University of Tsukuba Hospital, Approval #R01-030). Due to the nature of retrospective study, the acquisition of informed consent from patients was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors declare that no conflicts of interest exist.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"352"}}